Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-20T20:12:14.497Z Has data issue: false hasContentIssue false

Chapter 15 - Blood Group Incompatibilities and Transfusion Support after Hematopoietic Cell Transplant

from Section 4 - Early Post-Transplant Interval

Published online by Cambridge University Press:  24 May 2017

Hillard M. Lazarus
Affiliation:
Case Western Reserve University, Ohio
Robert Peter Gale
Affiliation:
Imperial College London
Armand Keating
Affiliation:
University of Toronto
Andrea Bacigalupo
Affiliation:
Ospedale San Martino, Genoa
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Kerry Atkinson
Affiliation:
University of Queensland
Syed Ali Abutalib
Affiliation:
Midwestern Regional Medical Center, Cancer Treatment Centers of America, Chicago
Get access
Type
Chapter
Information
Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
, pp. 123 - 130
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Goldman, J, Liesveld, J, Nichols, D, et al. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 2003; 27:489–91.CrossRefGoogle ScholarPubMed
Remberger, M, Watz, E, Ringden, O, Mattsson, J, Shjanwell, A, Wikman, A. Major ABO blood group mismatch increases the risk for graft failure after, unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007;13(6):675–82.Google ScholarPubMed
Buckner, CD, Clift, RA, Sanders, JE, et al. ABO-incompatible marrow transplants. Transplantation 1978; 26:233–8.CrossRefGoogle ScholarPubMed
Warkentin, Pl, Yomtovian, R, Hurd, D, et al. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation. Vox Sang 1983; 45:40–7.Google ScholarPubMed
Klummp, TR, Herman, JH, Ulicny, J, et al. Lack of effect of donor-recipient ABO mismatching outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38:615–20.Google Scholar
Curley, C, Pillai, E, Mudie, K, et al. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secreter plasma with or without plasma exchange. Transfusion 2012; 52:291–7.CrossRefGoogle ScholarPubMed
Robeck, JD, Grossman, BJ, Harris, T, Hillyer, CD. Technical manual. Bethesda, MD: AABB; 2011.Google Scholar
Bender, JG, Bikto, L, Williams, S, et al. Defining a therapy dose of peripheral blood stem cells. J Hematother 1992; 1:329–41.CrossRefGoogle ScholarPubMed
Rowley, SD. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant 2001; 28(4):315–21.CrossRefGoogle ScholarPubMed
Cohn, C, Gaensler, K, Nambiar, A. Engraftment associated complications: Is it an allo-or an autoantibody? Transfusion 2010; 50(2S).Google Scholar
Akel, S, Regan, D, Petz, L, McCullough, J. Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomes. Transfusion 2014; 54(11):29973009.CrossRefGoogle ScholarPubMed
Stroncek, DF, Fautsch, SK, Lasky, LC, Hurd, DD, Ramsay, NKC, McCullough, J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31:521–7.CrossRefGoogle ScholarPubMed
Malfuson, JV, Amor, RB, Bonin, P, Rodet, M, Boccaccio, C, Pautas, C, et al. Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation. Vax Sang 2007; 92(1):85–9.Google ScholarPubMed
Petz, LD. Immune hemolysis associated with transplantation. Semin Hematol 2005; 42(3):145–55.CrossRefGoogle ScholarPubMed
Fleur, MA, Lichtiger, B, Bassett, R, et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietc cell transplantation. Br J Haematol 2013; 160:798805.Google Scholar
Yazar, MH, Triulzi, DJ. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007; 14:664–70.Google Scholar
Karafin, MS, Blagg, L, Tobian, AA, et al. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012; 52:2087–93.CrossRefGoogle Scholar
Mollison, P, Engelfriet, C, Contreras, M, editors. ABO, lewis and P groups and l antigens. 10th ed. Oxford, UK: Blackwell Science; 1997.Google Scholar
Petz, LO. Hemolysis associated with transplantation. Transfusion 1998; 38:224–8.CrossRefGoogle ScholarPubMed
Bolan, CD, Childs, RW, Proter, JL, et al. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 2001; 112:787–95.CrossRefGoogle ScholarPubMed
Daniel-Johnson, J, Schwartz, J. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation? Transfusion 2011; 51:1143–9.CrossRefGoogle ScholarPubMed
Gajewski, JL, Johnson, VV, Sandler, SG, et al. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 2008; 112:3036–47.CrossRefGoogle ScholarPubMed
McCullough, J. Transfusion medicine. 3rd ed, Chapter 8. Oxford, UK: Wiley-Blackwell; 2012: 1597.Google Scholar
Boctor, FN, Ali, NM, Mohandas, K, et al. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003; 43:(2):173–6.CrossRefGoogle ScholarPubMed
Ramsey, G, Hahn, LF, Cornell, FW, et al. Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989; 47(6):993–5.CrossRefGoogle ScholarPubMed
Cummins, D, Contreras, M, Amin, S, et al. Red cell alloantibody development associated with heart and lung transplantation. Transplantation 1995; 59:1432–5.CrossRefGoogle ScholarPubMed
Casanueva, M, Valdes, MD, Ribera, MC. Lack of alloimmunisation to D antigen in D-negative immunosuppressed liver transplant patients. Transfusion 1994; 34:570–2.CrossRefGoogle Scholar
Menitove, JE. Immunoprophylaxis for D-patients receiving platelets from D+ donors? Transfusion 2002; 42:136–8.CrossRefGoogle ScholarPubMed
Abou-Elells, AA, Camarillo, TA, Allen, BM, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995; 35:931–5.Google Scholar
Parkman, R. Immunological reconstitution following bone marrow transplantation. In Bone marrow transplantation. Boston, MA: Blackwell Scientific; 1994; 504–12.Google ScholarPubMed
Atkinson, K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5(4):209–26.Google ScholarPubMed
Friedberg, RC. Transfusion therapy in the patient undergoing hematopoietic stem cell transplantation. Hematol Oncol Clin North Am 1994; 8(6):1105–16. Review.CrossRefGoogle ScholarPubMed
Heddle, NM, Soutar, RL, O’Hoski, PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91(4):1000–5.CrossRefGoogle ScholarPubMed
Azuma, E, Nishihara, H, Hanada, M. Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide. Bone Marrow Transplant 1996; 18(1):243–6.Google ScholarPubMed
Wennerberg, A, Backman, KA, Gillerlain, C. Mixed erythrocyte chimerism: implications for tolerance of the donor immune system to recipient non-ABO system red cell antigens. Bone Marrow Transplant 1996; 18(2):433–5.Google ScholarPubMed
Sachs, V. Immune haemolysis after organ transplantation. Transf Med 1995; 5(1):87.CrossRefGoogle ScholarPubMed
Chen, F, Owen, I, Savage, D, et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997; 19:491–5.CrossRefGoogle ScholarPubMed
Drobyski, WR, Potluri, J, Sauer, D, Gottschall, JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17(6):1093–9.Google ScholarPubMed
Horn, B, Viele, M, Mentzer, W, et al. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 1999; 24(9):1009–13.CrossRefGoogle Scholar
Mijovic, A. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. Vox Sang 2002; 83:358362.CrossRefGoogle ScholarPubMed
Erker, CG, Steins, MB, Fischer, RJ, et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005; 45:1382–90.CrossRefGoogle ScholarPubMed
Wirk, B, Klumpp, TR, Ulicny, J, et al. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion 2008; 48:163–8.CrossRefGoogle ScholarPubMed
Berkman, EM, Caplan, SN. Engraftment of RH-positive marrow in a recipient with RH antibody. Transplant Proc 1977; 9(1 Suppl 1):215–8.Google Scholar
Rigal, D, Monestier, M, Meyer, F, Tremisi, PJ, et al. Transplant of rhesus-positive bone marrow in a rhesus-negative woman having anti-rhesus D alloantibodies. Acta Haematol 1985; 73(3):153–6.CrossRefGoogle Scholar
Taylor, PA, Ehrhardt, MJ, Roforth, MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109:1307–15.CrossRefGoogle Scholar
Warkentin, PI, Hilden, JM, Kersey, JH, et al. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 1985; 48(2):89104.Google ScholarPubMed
Kalacioglu, M, Copelan, E, Avalos, B, et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995; 15:105–10.Google Scholar
Booth, GS, Gerhie, EA, Bolan, CD, Savani, BN. Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19:1152–8Google ScholarPubMed
Lichtiger, B, Hester, JP. Transfusion of Rh-incompatible blood components to cancer patients. Haematologia 1986; 19:81–8.Google ScholarPubMed
Asfour, M, Narvios, A, Lichtiger, B. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. Med Gen Med 2004; 13:22.Google Scholar
Goldfinger, D, MGinniss, MH. Rh-incompatible platelet transfusion: risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971; 284:942.CrossRefGoogle ScholarPubMed
McLeod, BC, Piehl, MR, Sassetti, RJ. Alloimmunizaation to RhD by platelet transfusion in autologous bone marrow transplant recipients. Vox Sang 1990; 59:185–9.CrossRefGoogle ScholarPubMed
Avache, S, Herman, JH. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG. Transfusion 2008; 48:1990–9.Google Scholar
Pfisterer, H, Thierfelder, S, Kottusch, H, et al. Examination of human thrombocytes for Rhesus antigens using decomposition studies in vivo following Cr 51 labelling. Klin Wochenschr 1967; 45(10):519–22.Google ScholarPubMed
Burnie, KM, Barr, RM. Unpublished observations cited by Mollsion, PL, Engelfriet, CP, Contreras, M. In Blood transfusion in clinical medicine, 9th edition. Oxford: Blackwell; 1993: 235.Google Scholar
McBride, JA, O’Hoski, P, Blasjchman, MA, et al. Rhesus alloimmunisation following intensive plasmapheresis. Transfusion 1978; 18:626–7.Google Scholar
O’Shaughnessy, DF, Atterbury, C, Bolton Maggs, P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Committee for Standards in Haematology, Blood Transfusion Task Force. Br J Haematol 2004; 126(1):1128.Google Scholar
Barclay, GR, Greiss, MA, Urbaniak, SJ. Adverse effect of plasma exchange on anti-D production in rhesus immunization owing to removal of inhibitory factors. BMJ 1980; 280(6231):1569–71.CrossRefGoogle ScholarPubMed
Schorr, JB, Schorr, PT, Francis, R, et al. The antigenicity of C and E antigens when transfused into Rh-negative (rr) and Rh-positive recipients. Chicago, IL: Commun Am Assoc Blood Banks; 1971.Google Scholar
Huestis, DW. International forum: what constitutes adequate routine Rh typing on donors and recipients? Vox Sang 1971; 21:183.Google Scholar
Leo, A, Mytilineos, J, Voso, MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion 2000; 40(6):632–6.CrossRefGoogle Scholar
Ting, A, Pun, A, Dodds, AJ, Atkinson, K, et al. Red cell alloantibodies produced after bone marrow transplantation. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987; 27(2):145–7.Google ScholarPubMed
de la Rubia, J, Arriaga, F, Andreu, R, et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001; 41:106–10.CrossRefGoogle ScholarPubMed
Zupańska, B, Zaucha, JM, Michalewska, B, et al. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation. Transfusion 2005; 45(1):1620.CrossRefGoogle ScholarPubMed
López, A, de la Rubia, J, Arriaga, F, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998; 38(3):247–51.CrossRefGoogle ScholarPubMed
Dinsmore, RE, Reich, LM, Kapoor, N, et al. ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation. Br J Haematol 1983; 54(3):441–9.CrossRefGoogle ScholarPubMed
Lasky, LC, Warkentin, PI, Kersey, JH, et al. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 1983; 23(4):277–85.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×